Similar organisations to The Shank2 Foundation
-
Children's and Youth Services
-
2035.
Glads Inc
Generating Learning and Appreciation for Down Syndrome OUR MISSION PEOPLE WITH DOWN SYNDROME ARE BEAUTIFUL.
Jericho
The Nick Gonzales Foundation for Brain Tumor Research
Our mission is to raise awareness of the early warning signs of brain tumors and critical funds for specific brain tumor/cancer research projects.
Carrollton
-
Fund Raising and/or Fund Distribution
-
2037.
Small Wonders Foundation
The Small Wonders Foundation provides information, encouragement and financial support to parents experiencing the difficulties of having children born with facial or body deformities.
664
LOS ANGELES
-
Birth Defects, Genetic Diseases
-
2038.
Springer Family Foundation Inc
Extra To Love aims to empower the Trisomy 13 and 18 communities through connection, financial support and education.
Justin
-
Family Services (Adolescent Parents)
-
2039.
Unlocked Inc
Our mission is to ease the financial burden of families raising children with disabilities by funding adaptive or medical equipment necessary to increase their mobility, gain independence, and promote physical, social, and emotional development.
223
Charlotte
-
Private Independent Foundations
-
2040.
Kathy Jerry Wood Foundation Inc
Our Foundation We are a private charitable foundation providing educational opportunities for children and young adults.
Annapolis
-
Rehabilitative Medical Services
-
2041.
Enhancing Skills for Life
Non-profit org (501c3) that supports individuals who are living without both arms or all four limbs.
1339
Houston
NATIONAL INSTITUTE FOR HEALTH CARE
NIHCM Foundation is a nonprofit, nonpartisan organization dedicated to transforming health care through evidence and collaboration for over 25 years.
552
WASHINGTON
-
Promotion of Business (Chambers of Commerce)
-
2043.
INDUSTRY PHARMACOGENOMICS WORKING GROUP
Welcome To The Pharmacogenomic Working Group The Industry Pharmacogenomics Working Group IPWG is an association of pharmaceutical and biotech companies who are actively engaged in the field of pharmacogenomic PGx research.
WASHINGTON


